Skip to content
HowShorted

ADIAL PHARMACEUTICALS, INC. short interest in 2021

In 2021, ADIAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 2.60% of shares outstanding on 15 Jan 2021 to 4.15% on 31 Dec 2021, a change of +1.55 percentage points. The year's high was 7.21% on 30 Jun 2021 and its low 2.43% on 29 Jan 2021, averaging 4.27% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.07 days on 15 Dec 2021. Full history: ADIAL PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ADIAL PHARMACEUTICALS, INC. in 2021

2021 in figures

Start of year
2.60% (15 Jan 2021)
End of year
4.15% (31 Dec 2021)
Change
+1.55 pp
High
7.21% (30 Jun 2021)
Low
2.43% (29 Jan 2021)
Average
4.27%
Highest days to cover
7.07 (15 Dec 2021)
SEC filings marked
4

Every report in 2021

ADIAL PHARMACEUTICALS, INC. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20212.60%1.00
29 Jan 20212.43%1.00
12 Feb 20213.30%1.00
26 Feb 20213.56%1.00
15 Mar 20213.85%1.46
31 Mar 20213.64%1.7410-K filed
15 Apr 20214.24%4.79
30 Apr 20213.83%4.71
14 May 20213.67%5.01
28 May 20214.09%5.8710-Q filed
15 Jun 20213.54%2.13
30 Jun 20217.21%1.00
15 Jul 20215.40%1.00
30 Jul 20216.32%4.20
13 Aug 20214.87%1.8710-Q filed
31 Aug 20214.38%1.07
15 Sep 20214.25%2.59
30 Sep 20214.69%1.91
15 Oct 20214.85%4.09
29 Oct 20214.31%2.56
15 Nov 20214.79%3.3910-Q filed
30 Nov 20214.53%2.80
15 Dec 20214.10%7.07
31 Dec 20214.15%6.34

See also: ADIAL PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.